A rapid & sensitive liquid chromatography-tandem mass spectrometry method for the quantitation of busulfan levels in plasma & application for routine therapeutic monitoring in haematopoietic stem cell transplantation

Indian Journal of Medical Research

Volumn 137, Issue 4, 2013, Pages 777-784

  Desire, Salamun ^a,b   Mohanan, Ezhil Pavai ^a   George, Biju ^a   Mathews, Vikram ^a   Chandy, Mammen ^a,c   Srivastava, Alok ^a   Balasubramanian, Poonkuzhali ^a  

^a CHRISTIAN MEDICAL COLLEGE   (India)

^b PSG INSTITUTE OF MEDICAL SCIENCES AND RESEARCH   (India)

^c Tata Medical Centre   (India)

Author keywords

Busulfan; HSCT; Mass spectrometry; Therapeutic monitoring

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; FLUDARABINE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; DIAGNOSTIC TEST ACCURACY STUDY; DRUG DOSE INCREASE; DRUG MEGADOSE; ELECTROSPRAY; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INFANT; LIMIT OF DETECTION; LIMIT OF QUANTITATION; MALE; MEASUREMENT ACCURACY; MEASUREMENT PRECISION; PRESCHOOL CHILD; QUANTITATIVE ANALYSIS; SCHOOL CHILD; SINGLE DRUG DOSE; TANDEM MASS SPECTROMETRY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; BUSULFAN; CHILD; CHILD, PRESCHOOL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG MONITORING; FEMALE; GRAFT REJECTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; MALE; MIDDLE AGED; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TANDEM MASS SPECTROMETRY; TRANSPLANTATION CONDITIONING;

EID: 84877747241     PISSN: 09715916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Santos GW. Busulfan (Bu) and cyclophosphamide (Cy) for marrow transplantation. Bone Marrow Transplant 1989; 4 (Suppl 1): 236-9.
2. Santos GW. The development of busulfan/cyclophosphamide preparative regimens. Semin Oncol 1993; 20: 12.
3. Santos GW. Busulfan and cyclophosphamide versus cyclophosphamide and total body irradiation for marrow transplantation in chronic myelogenous leukemia-a review. Leuk Lymphoma 1993; 11 (Suppl 1): 201-4.
4. Vassal G, Gouyette A, Hartmann O, Pico JL, Lemerle J. Pharmacokinetics of high-dose busulfan in children. Cancer Chemother Pharmacol 1989; 24: 386-90.
5. Poonkuzhali B, Srivastava A, Quernin MH, Dennison D, Aigrain EJ, Kanagasabapathy AS, et al. Pharmacokinetics of oral busulphan in children with beta thalassaemia major undergoing allogeneic bone marrow transplantation. Bone Marrow Transplant 1999; 24: 5-11.
6. Grochow LB. Busulfan disposition: the role of therapeutic monitoring in bone marrow transplantation induction regimens. Semin Oncol 1993; 20: 18-25; quiz 26.
7. Grochow LB, Jones RJ, Brundrett RB, Braine HG, Chen TL, Saral R, et al. Pharmacokinetics of busulfan: correlation with veno-occlusive disease in patients undergoing bone marrow transplantation. Cancer Chemother Pharmacol 1989; 25: 55-61.
8. Ljungman P, Hassan M, Bekassy AN, Ringden O, Oberg G. High busulfan concentrations are associated with increased transplant-related mortality in allogeneic bone marrow transplant patients. Bone Marrow Transplant 1997; 20: 909-13.
9. Slattery JT, Sanders JE, Buckner CD, Schaffer RL, Lambert KW, Langer FP, et al. Graft-rejection and toxicity following bone marrow transplantation in relation to busulfan pharmacokinetics. Bone Marrow Transplant 1995; 16: 31-42.
10. Vassal G, Koscielny S, Challine D, Valteau-Couanet D, Boland I, Deroussent A, et al. Busulfan disposition and hepatic veno-occlusive disease in children undergoing bone marrow transplantation. Cancer Chemother Pharmacol 1996; 37: 247-53.
11. Bolinger AM, Zangwill AB, Slattery JT, Risler LJ, Sultan DH, Glidden DV, et al. Target dose adjustment of busulfan in pediatric patients undergoing bone marrow transplantation. Bone Marrow Transplant 2001; 28: 1013-8.
12. Vassal G, Re M, Gouyette A. Gas chromatographic-mass spectrometric assay for busulfan in biological fluids using a deuterated internal standard. J Chromatogr 1988; 428: 357-61.
13. Chen TL, Grochow LB, Hurowitz LA, Brundrett RB. Determination of busulfan in human plasma by gas chromatography with electron-capture detection. J Chromatogr 1988; 425: 303-9.
14. Blanz J, Rosenfeld C, Proksch B, Ehninger G, Zeller KP. Quantitation of busulfan in plasma by high-performance liquid chromatography using postcolumn photolysis. J Chromatogr 1990; 532: 429-37.
15. Heggie JR, Wu M, Burns RB, Ng CS, Fung HC, Knight G, et al. Validation of a high-performance liquid chromatographic assay method for pharmacokinetic evaluation of busulfan. J Chromatogr B Biomed Sci Appl 1997; 692: 437-44.
16. Quernin MH, Poonkuzhali B, Montes C, Krishnamoorthy R, Dennison D, Srivastava A, et al. Quantification of busulfanin plasma by gas chromatography-mass spectrometry following derivatization with tetrafluorothiophenol. J Chromatogr B Biomed Sci Appl 1998; 709: 47-56.
17. Peris JE, Latorre JA, Castel V, Verdeguer A, Esteve S, Torres-Molina F. Determination of busulfan in human plasma using high-performance liquid chromatography with pre-column derivatization and fluorescence detection. J Chromatogr B Biomed Sci Appl 1999; 730: 33-40.
18. Quernin MH, Poonkuzhali B, Medard Y, Dennison D, Srivastava A, Krishnamoorthy R, et al. High-performance liquid chromatographic method for quantification of busulfan in plasma after derivatization by tetrafluorothiophenol. J Chromatogr B Biomed Sci Appl 1999; 721: 147-52.
19. Quernin MH, Duval M, Litalien C, Vilmer E, Aigrain EJ. Quantification of busulfan in plasma by liquid chromatography-ion spray mass spectrometry. Application to pharmacokinetic studies in children. J Chromatogr B Biomed Sci Appl 2001; 763: 61-9.
20. Kellogg MD, Law T, Sakamoto M, Rifai N. Tandem mass spectrometry method for the quantification of serum busulfan. Ther Drug Monit 2005; 27: 625-9.
21. Snyder ML, Ritchie JC. Quantification of busulfan in plasma using liquid chromatography electrospray tandem mass spectrometry (HPLC-ESI-MS/MS). Methods Mol Biol 2010; 603: 129-36.
22. Juenke JM, Miller KA, McMillin GA, Johnson-Davis KL. An automated method for supporting busulfan therapeutic drug monitoring. Ther Drug Monit 2011; 33: 315-20.
23. Vaughan WP, Carey D, Perry S, Westfall AO, Salzman DE. A limited sampling strategy for pharmacokinetic directed therapy with intravenous busulfan. Biol Blood Marrow Transplant 2002; 8: 619-24.